Key points are not available for this paper at this time.
Analysis of tumor DNA in plasma and urine samples both separately and combined has a potential to predict treatment response and outcome.
Christensen et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: